Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446049
What this trial is testing
A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Who this might be right for
Locally Advanced or Metastatic Solid TumorsPTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd. 180